-
Personalized Therapies for Young Women’s ER-Positive Breast Cancer
03 Feb 2026 17:28 GMT
… positive early-stage breast cancer experience significantly … breast cancer remains endocrine therapy. Over decades, tamoxifen and aromatase inhibitors … ER-positive breast cancer. Immune cell … suppression in breast cancer treatmentpersonalized therapies …
-
Oxford joins study on insulin's impact in breast cancer treatment
01 Feb 2026 13:23 GMT
… breast cancer accounts for the majority of breast cancer … their proliferation.
Aromatase inhibitors, such as … of breast cancer and increased breast cancer-related … aromatase inhibitors, which are among the most widely used treatments in breast cancer …
-
<![CDATA[Palbociclib Maintenance Extends PFS in HR+/HER2+ Advanced Breast Cancer]]>
30 Jan 2026 00:25 GMT
… these findings for the global breast cancer community,” Otto Metzger, MD, … this challenging subtype of metastatic breast cancer.”
PATINA Trial Details
The … Endocrine therapy included either an aromatase inhibitor or fulvestrant (Faslodex). Randomization was …
-
Aviva Bio Announces FDA Guidance on Development Pathway for Women’s Testosterone Therapy and New Evidence of a Reduced Risk of Breast Cancer Cell Proliferation for AVA-291
26 Jan 2026 14:58 GMT
… potential to stimulate breast cancer cell proliferation compared … linked with potential safety (breast cancer) and tolerability (gynecomastia) … Early Breast Cancer Trialists’ Collaborative Group. Aromatase inhibitors versus tamoxifen in early breast cancer: …
-
<![CDATA[FDA Grants Priority Review to Gedatolisib for HR+, HER2-Negative Advanced Breast Cancer]]>
21 Jan 2026 17:28 GMT
… 47;6 inhibitor and aromatase inhibitor therapy.2 Participants were … HR+/HER2- Breast Cancer
Breast cancer remains an established cause … HR+/HER2- breast cancer lacking PIK3CA mutation by … wild-type (WT) advanced breast cancer (ABC): First results …
-
<![CDATA[FDA Grants Priority Review to Gedatolisib for Advanced Breast Cancer]]>
21 Jan 2026 01:40 GMT
… locally advanced or metastatic breast cancer. This indication applies … 6 inhibitor and an aromatase inhibitor.
The submission was … ;PIK3CA wild-type advanced breast cancer. News release. Celcuity … metastatic HR+/HER2- breast cancer (VIKTORIA-1) (VIKTORIA …
-
<![CDATA[FDA Accepts NDA for Gedatolisib in HR+/HER2–, PIK3CA Wild-Type Breast Cancer]]>
20 Jan 2026 22:44 GMT
… HR+/HER2- advanced breast cancer,” Brian Sullivan, chief … metastatic or locally advanced breast cancer. Eligible patients had … with a non-steroidal aromatase inhibitor.
A total of 392 … 47;PIK3CA wild-type advanced breast cancer. News release. Celcuity. …
-
Cannabis-Infused Balms Reduce Pain for Patients with Breast Cancer
20 Jan 2026 22:08 GMT
… Cannabinoid Research showed breast cancer patients taking prescribed aromatase inhibitors (estrogen-blocking drugs … (THC) and cannabidiol (CBD).
Breast cancer is the most common cancer … in decreasing AIMSS severity in breast cancer patients.
Sources: Cannabis …
-
Prosthetic Loosening in a Total Hip Arthroplasty Patient After Breast Cancer Chemotherapy and Hormonal Therapy: A Case Report
16 Jan 2026 22:27 GMT
… loosening.
Breast cancer is the … breast cancer chemotherapy and hormonal therapy, particularly aromatase inhibitors …
Conclusion
Breast cancer chemotherapy and … aromatase inhibitor-associated bone loss in postmenopausal women with hormone-sensitive breast cancer …
-
Fast Five Quiz: Key Aspects of Metastatic Breast Cancer
15 Jan 2026 17:52 GMT
… with other breast cancer subtypes.
Learn more about breast cancer.
Clinical N3 breast cancer indicates ipsilateral … alone, sequential hormonal therapy, nonsteroidal aromatase inhibitors with ovarian ablation or ovarian …
About
© 1995-2026